Adults Regulating Their Weight Everyday With Mobile Internet Support

N/AActive Not RecruitingNCT05787652

University of Oxford1,294 enrolled

Overview

Adults Regulating Their weight Everyday with Mobile Internet Support (ARTEMIS) is a randomised controlled trial evaluating the effectiveness of a mobile app based weight loss intervention designed to increase self-regulation in adults living with obesity.

Adults Regulating Their weight Everyday with Mobile Internet Support (ARTEMIS) is a randomised, controlled trial examining the effectiveness of the self-regulation intervention to promote weight loss, when delivered through a mobile application, with no in-person contact, among a sample of \~ 1,294 adults living with obesity in the United Kingdom. Further, the investigators will assess the safety of the intervention regarding any a potential unintended consequence, which is the development of disordered eating. The intervention comprises daily self-weighing and daily reflection on the day's task of controlling weight through implementation of actions, and selection of new actions for the next day. It encourages users to build up a repertoire of actions for life that suit them in controlling weight.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

1,294

Conditions

Obesity

Interventions

ARTEMIS mobile appBEHAVIORAL

Access to a self-regulation based mobile application.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Participation is open to those who meet the following eligibility criteria: * aged ≥ 18 years; * living with obesity (BMI ≥ 30 if of white ethnicity; ≥ 27.5 for all other ethnic groups); * full- time residents in the UK, without the intention to move outside the UK within the next 12 months; * able to access the internet with a smartphone; * able to access and use a digital weighing scale; * can understand English; * not presently signed up with an intention to attend, or have in the previous three months attended, a weight management programme; * not currently participating in another weight management study; * not lost \> 5 kg (10 pounds) body weight in the previous six months; * not undergone bariatric surgery, or presently scheduled to have bariatric surgery; * not pregnant, or planning a pregnancy in the next 12 months; * not previously been diagnosed with an eating disorder; * not recently been diagnosed with a disease, or expected to undergo treatment for a disease, associated with substantial weight loss e.g., cancer treatment.

Locations (1)

Online social media platforms (Meta (Facebook, Instagram, Google, Twitter)

London, United Kingdom

Outcomes

Primary Outcomes

Change in body weight

To assess if the intervention achieves significantly greater weight loss than the no-treatment control group.

Time frame: 6 months (baseline to 26-week follow up)

Proportion of participants achieving ≥ 5% loss in body weight

To assess if the intervention achieves significantly greater weight loss than the no-treatment control group.

Time frame: 6 months (baseline to 26-week follow up)

Secondary Outcomes

Change in body weight

To assess if the intervention achieves significantly greater weight loss than the no-treatment control group in the short term.

Time frame: 12 weeks (baseline to 12-week follow up)

Proportion of participants achieving ≥ 5% loss in body weight

To assess if the intervention achieves significantly greater weight loss than the no-treatment control group in the short term.

Time frame: 12 weeks (baseline to 12-week follow up)

Change in the proportion of participants scoring above threshold (> 7) on a modified Eating Disorders Examination - Questionnaire Short Form (EDE-QS)

To assess the impact of self-regulation intervention on disordered weight control. Note. the modified Eating Disorders Examination - Questionnaire Short Form (EDE-QS) has a maximum score of 18, with higher scores being indicative of disordered eating.

Time frame: 12- and 26-week follow up (baseline to 12 and 26-week follow up)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.